Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$717M |
| 2 |
McKesson
MCK
|
+$678M |
| 3 |
DuPont de Nemours
DD
|
+$670M |
| 4 |
Boeing
BA
|
+$636M |
| 5 |
Intercontinental Exchange
ICE
|
+$628M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$829M |
| 2 |
GE Aerospace
GE
|
+$634M |
| 3 |
RTN
Raytheon Company
RTN
|
+$537M |
| 4 |
Baxter International
BAX
|
+$535M |
| 5 |
PX
Praxair Inc
PX
|
+$520M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.53% |
| 2 | Financials | 14.78% |
| 3 | Technology | 11.19% |
| 4 | Industrials | 11% |
| 5 | Consumer Discretionary | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Neurocrine Biosciences
NBIX
$16.8B
| $20.9M | 0.01% |
460,074
+39,902
| +9% | +$1.84M |
|
927
Sprouts Farmers Market
SFM
$8.13B
| $20.9M | 0.01% |
912,093
+31,459
| +4% | +$805K |
|
928
NVE Corp
NVEC
$562M
| $20.5M | 0.01% |
350,053
+36,865
| +12% | +$2.1M |
|
929
Financial Institutions
FISI
$816M
| $20.5M | 0.01% |
787,189
-303,039
| -28% | -$8.35M |
|
930
AngloGold Ashanti
AU
$40.1B
| $20.5M | 0.01% |
1,135,207
-1,662,739
| -59% | -$25.3M |
|
931
NN Inc
NNBR
$255M
| $20.4M | 0.01% |
1,460,013
-97,760
| -6% | -$1.54M |
|
|
UCFC
932
DELISTED
United Community Financial Corp
UCFC
| $20.3M | 0.01% |
3,336,060
-546,182
| -14% | -$3.23M |
|
933
US Physical Therapy
USPH
$1.2B
| $20.3M | 0.01% |
336,435
+6,581
| +2% | +$361K |
|
934
Texas Capital Bancshares
TCBI
$4.3B
| $20.2M | 0.01% |
432,638
+28,428
| +7% | +$1.27M |
|
|
MYOK
935
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $20.2M | 0.01% |
1,628,083
+34,596
| +2% | +$432K |
|
|
SRDX
936
DELISTED
Surmodics
SRDX
| $20.2M | 0.01% |
858,217
+173,702
| +25% | +$3.81M |
|
|
CAI
937
DELISTED
CAI International, Inc.
CAI
| $20.1M | 0.01% |
2,686,058
-46,443
| -2% | -$393K |
|
938
PTC
PTC
$15.8B
| $20.1M | 0.01% |
535,456
+60,063
| +13% | +$2.15M |
|
|
ONCE
939
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $20.1M | 0.01% |
392,994
-43,238
| -10% | -$1.85M |
|
|
NVRO
940
DELISTED
NEVRO CORP.
NVRO
| $20.1M | 0.01% |
+271,833
| New | +$18.4M |
|
|
GPX
941
DELISTED
GP Strategies Corp.
GPX
| $20M | 0.01% |
922,825
+174,518
| +23% | +$4.16M |
|
942
Matador Resources
MTDR
$6.2B
| $20M | 0.01% |
1,009,226
-113,044
| -10% | -$2.43M |
|
943
Infosys
INFY
$48.7B
| $19.9M | 0.01% |
2,226,240
-994,502
| -31% | -$9.3M |
|
944
Hercules Capital
HTGC
$3.07B
| $19.7M | 0.01% |
1,586,949
+181,455
| +13% | +$2.2M |
|
|
CBIO
945
Crescent Biopharma
CBIO
$537M
| $19.7M | 0.01% |
27,103
+413
| +2% | +$285K |
|
|
LBAI
946
DELISTED
Lakeland Bancorp Inc
LBAI
| $19.6M | 0.01% |
1,720,535
-141,096
| -8% | -$1.57M |
|
|
ACOR
947
DELISTED
Acorda Therapeutics
ACOR
| $19.5M | 0.01% |
6,381
-8,229
| -56% | -$26.8M |
|
948
Brookdale Senior Living
BKD
$3.49B
| $19.4M | 0.01% |
1,258,514
+29,572
| +2% | +$516K |
|
949
Kaiser Aluminum
KALU
$2.61B
| $19.4M | 0.01% |
214,286
-3,972
| -2% | -$347K |
|
950
CareTrust REIT
CTRE
$9.91B
| $19.4M | 0.01% |
1,405,824
-657,814
| -32% | -$8.69M |
|
Similar funds
Wellington Management Group's Q2 2016 Portfolio in Review
As of Q2 2016, Wellington Management Group held 2,304 positions worth $387B, up 1.8% from $380B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Wellington Management Group's Q2 2016 filing shows 190 new, 804 increased, 889 reduced and 231 closed positions. Its largest new stake was S&P Global: 4,185,291 shares worth $449M. The largest sale was RTX Corp, an estimated $829M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q2 2016 buy was S&P Global: 4,185,291 shares worth $449M.
- Wellington Management Group added most to Allergan plc in Q2 2016, an estimated $717M increase.
- Wellington Management Group's biggest Q2 2016 reduction was RTX Corp, cutting an estimated $829M.
- Wellington Management Group fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $236M.
- Wellington Management Group's ten largest holdings make up 17% of its $387B portfolio in Q2 2016.
- Wellington Management Group opened 190 new positions and closed 231 in Q2 2016.
- Wellington Management Group's portfolio value rose 1.8% quarter-over-quarter to $387B.
Based on Wellington Management Group's 13F filing for Q2 2016, filed 15 Aug 2016.